Metobeta Retard

Metoprolol Tartrate, the active ingredient in Metobeta Retard, is a beta blocker presented as an oral tablet for oral use. It is employed to manage hypertension, angina pectoris, post‑myocardial infarction care, heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metobeta Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation and responsive technical support throughout the procurement process.

Metobeta Retard (metoprolol tartrate) is a selective β1‑adrenergic blocker used in cardiovascular disease management.

- Hypertension: lowers systolic and diastolic pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Heart failure: improves ventricular filling and reduces mortality in chronic systolic failure. - Post‑myocardial infarction: lowers risk of recurrent infarction and arrhythmic events. - Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Metobeta Retard may cause a range of adverse reactions. Monitoring and patient counseling are essential.

Common Side Effects: - Fatigue: feeling of tiredness or reduced energy. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced peripheral circulation.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Hypotension: markedly low blood pressure causing faintness. - Bronchospasm: difficulty breathing, particularly in patients with asthma. - Allergic reactions: rash, itching, swelling or anaphylaxis.

Before initiating therapy, clinicians should consider several safety measures.

- Blood pressure monitoring: ensure adequate control and avoid excessive hypotension. - Heart rate assessment: verify baseline rate and watch for bradycardia. - Asthma or chronic obstructive pulmonary disease: use with caution due to potential bronchoconstriction. - Discontinuation: avoid abrupt cessation to prevent rebound tachycardia and hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metobeta Retard can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of heart block.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may mask hypoglycemia symptoms. - NSAIDs: can reduce antihypertensive effect. - Antidepressants (SSRIs, SNRIs): may enhance bradycardia.